CME 2026 ASLMS 45th Annual Conference Recordings - Ink & Hue: Mastering Laser Removal of Tattoos and Pigmented Lesions
The course was recorded on May 9, 2026, at the ASLMS Annual Conference.
Course Description: Laser treatment of tattoos and pigmentary disorders in skin of color carries a higher risk of complications and requires specialized clinical expertise. This course provides an evidence-based, practical approach to device selection, and parameter optimization to minimize complications in darker skin types.
COURSE DIRECTORS: Girish S. Munavalli, MD, MHS, FACMS – Medical Director/Founder, Dermatology Laser and Vein Specialists of the Carolinas; Nazanin Saedi, MD
FACULTY PANELISTS: B. S. Chandrashekar, MD; William Kwan, MD, FAAD; Omar A. Ibrahimi, MD, PhD; Boncheol L. Goo, MD, MSc
LEARNING OBJECTIVES:
At the end of the activity, learners should be able to:
- Select appropriate laser devices for tattoo removal and pigmentary disorders in Fitzpatrick skin types IV–VI based on diagnosis and patient-specific risk factors.
- Implement evidence-based peri-procedural strategies to reduce pigmentary complications in skin of color.
TARGET AUDIENCE:
This activity is intended for an audience of physicians and other healthcare professionals interested in the use of lasers, light, energy-based devices, and related technologies across various specialties.
PRESENTATIONS:
The Science of Dyspigmentation | B. S. Chandrashekar, MD
Tattoo Removal 360 | William Kwan, MD, FAAD – Physician, Golden State Dermatology Beverly Hills
Minimizing Pigment in Skin of Color | Omar A. Ibrahimi, MD, PhD – Founding Medical Director, Connecticut Skin Institute
Best Practices for Treating Skin of Color | Boncheol L. Goo, MD, MSc – Chief Director, Naeum Dermatology and Aesthetics Clinic, Seoul, Korea
DISCLOSURES:
The American Society for Laser Medicine and Surgery (ASLMS) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME), stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by ASLMS are required to disclose all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by ASLMS in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by ASLMS to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by ASLMS.
All planners and faculty for this educational activity, except for those listed below, have no financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
- Girish S. Munavalli, MD, MHS, FACMS discloses the following financial relationships: Allergan Abbvie: Consulting Fees (e.g., advisory boards), Honoraria, Speakers' Bureau; Benev: Consulting Fees (e.g., advisory boards), Honoraria, Speakers' Bureau; Candela: Consulting Fees (e.g., advisory boards), Honoraria, Speakers' Bureau, Stock Options Holder; Evolus: Consulting Fees (e.g., advisory boards), Honoraria; Lumenis: Consulting Fees (e.g., advisory boards), Honoraria, Speakers' Bureau; Lutronic: Consulting Fees (e.g., advisory boards), Honoraria, Speakers' Bureau; Sofwave: Consulting Fees (e.g., advisory boards), Honoraria, Speakers' Bureau; Sofwave Medical: Contracted Research (Principal Investigators must provide information, even if received by the institution), Stock Options Holder
- Nazanin Saedi, MD discloses the following financial relationships: Aerolase: Consulting Fees (e.g., advisory boards); Alastin Skincare, Inc./Galderma: Consulting Fees (e.g., advisory boards); Cartessa Aesthetics: Consulting Fees (e.g., advisory boards); Epionce: Consulting Fees (e.g., advisory boards); Grande Cosmetics: Consulting Fees (e.g., advisory boards); Hydrafacial: Consulting Fees (e.g., advisory boards); Revision Skin Care: Contracted Research (Principal Investigators must provide information, even if received by the institution); Sciton Inc.: Consulting Fees (e.g., advisory boards)
- William Kwan, MD, FAAD discloses the following financial relationships: Candela: Speakers' Bureau; Removery LLC.: Consulting Fees (e.g., advisory boards), Employee
- Omar A. Ibrahimi, MD, PhD, discloses the following financial relationships: AbbVie: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed) (Ongoing); Accure Acne: Consulting Fees (e.g., advisory boards); Cynosure-Lutronic: Consulting Fees (e.g., advisory boards); Cytrellis: Consulting Fees (e.g., advisory boards) (Ongoing); Pfizer: Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed) (Ongoing); Quthero: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed) (Ongoing); Regeneron Pharmaceutical: Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed) (); Unilever: Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed) (Ongoing)
- Boncheol L. Goo, MD, MSc, discloses the following financial relationships: AGNES Medical: Stock Options Holder, Stock Shareholder (Individual stocks; diversified mutual funds do not need to be disclosed); Classys: Consulting Fees (e.g., advisory boards); Colgage-Palmolive: Consulting Fees (e.g., advisory boards); Joonghun Pharma: Consulting Fees (e.g., advisory boards), Contracted Research (Principal Investigators must provide information, even if received by the institution), Honoraria; SheNB: Consulting Fees (e.g., advisory boards)
ASLMS staff planners and reviewers have no relevant financial relationships to disclose.
ACCME Accreditation Statement:
The American Society for Laser Medicine and Surgery, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement:
The American Society for Laser Medicine and Surgery, Inc. designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credits:
This enduring material is eligible for 1.6 CE credits if you are a Registered Nurse. These credits are provided with co-sponsorship with the Laser Training Institute division of Professional Medical Education Association.
Instructions for Learners to Receive Credit:
To receive a Certificate of Credit or a Certificate of Participation for the On-Demand (2026) course, registered attendees must submit a completed electronic CME/CE evaluation by the course expiration date (11/30/26).
This course should take approximately 1.5 hours to complete.
REFUND/CANCELLATION POLICY:
For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283.
- Refund requests will only be considered if made within 14 days of purchase.
- Refunds will only be considered if you have not yet started the course (no content viewed).
- Refunds are not available for missed live activities.
- Contact information@aslms.org to request a refund.
CONTACT INFORMATION:
For questions related to claiming CME or CE credits, please contact education1@aslms.org or call (715) 845-9283.
DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
DISCLOSURE OF OFF-LABEL USE:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Society for Laser Medicine & Surgery does not recommend the use of any agent outside of the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
Girish Munavalli, MD, MHS, FACMS (Moderator)
Dr. Munavalli is medical director and founder of Dermatology, Laser and Vein Specialists of the Carolinas in Charlotte, NC. He trained in Dermatology at Emory University School of Medicine and received board certified in 2002, and recertification in 2012 and 2022. He is dual board certified in Mohs Micrographic surgery.
Dr. Munavalli’s memberships and academic affiliations include:
Board certified and Fellow of American Academy of Dermatology
Board Certified and Fellow of the American College of Mohs Surgery
Fellow - American Society for Laser Medicine and Surgery
Fellow - American Society for Dermatologic Surgery
Academic affiliation - Assistant Clinical Professor of Dermatology at the Wake Forest University Department of Dermatology
-Author of over 90 peer reviewed publications and has given over 275 lectures nationally and internationally.
Editorial Board of LSM Journal and Lasers in Medical Science
Board of Directors - Intersocietal Accreditation Commission
Nazanin Saedi, MD (Moderator)
Dr. Nazanin Saedi is currently an Assistant Professor in the Department of Dermatology and Cutaneous Biology at Thomas Jefferson University, and she serves as Director of Laser Surgery and Cosmetic Dermatology. She graduated cum laude with a bachelor’s degree from Princeton University. She completed her medical education at The George Washington University School of Medicine, where she graduated with distinction and with Alpha Omega Alpha honors. Dr. Saedi completed her dermatology residency at the University of California, Irvine, and she completed her fellowship training at SkinCare Physicians in Chestnut Hill, Massachusetts. Dr. Saedi has authored over 100 peer-reviewed publications and book chapters. She lectures nationally and internationally on laser surgery and cosmetic dermatology.
B. S. Chandrashekar, MD
Dr. B. S. Chandrashekar
Chief Dermatologist & Managing Director – CUTIS Academy, Bengaluru
Chairman – CUTIS Group
Email: cacs0312@hotmail.com | Mobile: +91-9740091155
I am a dermatologist with over 30 years of experience in clinical practice, academic teaching, research, and organizational leadership. I hold MBBS, MD, and DNB in Dermatology and began my career as faculty at JSS Medical College and Dr. B.R. Ambedkar Medical College before establishing CUTIS Academy of Cutaneous Sciences, affiliated with Rajiv Gandhi University of Health Sciences. CUTIS is now a recognized center for dermatology education, fellowship training, and clinical research.
Academically, I have authored multiple textbook chapters, served as Editor-in-Chief of the IADVL Textbook of Trichology and Difficult to Treat Hair and Scalp disorders and published over 80 papers in national and international journals. I have conducted more than 100 clinical trials in acne, pigmentation, psoriasis, vitiligo, hair disorders, lasers, and aesthetic dermatology, with a patient database exceeding 15 lakh cases, including 6 lakh trichology cases. I supervise over 25,000 dermatology procedures annually, ranging from lasers to hair restoration surgery
I have held several leadership roles in dermatology organizations, including Scientific Chair, Dermacon International 2019, Secretary General, World Congress of Cosmetic Dermatology 2017, and Academic Chair, ACSI 2023–24. I am also a past president of KN IADVL and have contributed to SIG Trichology initiatives.
I am the recipient of numerous awards and orations, including the Dr. AK Bajaj Oration (DERMACON 2025), Prof. T.C. Saikia Memorial Oration (2024), Economic Times Inspiring Dermatologist Award (2019), and Karnataka Vaidya Ratna (2012).
My professional interests encompass clinical dermatology, trichology, lasers, aesthetic dermatology, biologics, and practice management. With my experience in academic leadership, research, and organizational activities, I aim to contribute to ACSI by strengthening academic initiatives, promoting collaborative research, and mentoring the next generation of dermatologists.
William Kwan, MD, FAAD, Member ASLMS
Board Certified Dermatologist - Lasky Skin Center; Clinical Advisory Board Chair - Removery
Removery, Austin, TX
Dr. Kwan received a B.S. in biology from UCLA, magna cum laude, and completed his medical training at USC. He executed an internship at the University of Rochester Medical Center and returned to Los Angeles for a residency at UCLA. He became the Chief Resident of dermatology at King/Drew Medical Center in Los Angeles. He then opened his own practice in San Francisco, California, which he successfully ran for many years before moving to southern California to be closer to his family.
Dr. Kwan is a prominent board-certified dermatologist, practicing both medical and cosmetic dermatology in Beverly Hills. Dr. Kwan combines sophisticated technology with a commitment to the highest standards of patient care. He is among the nation's leading practitioners of laser skin procedures and offers a full range of services to help each patient achieve healthy, beautiful skin.
Omar Ibrahimi, MD, PhD
Dr. Omar A. Ibrahimi is the founding and medical director of the Connecticut Skin Institute. He is a board certified Dermatologist who has completed advanced fellowship training in Skin Cancer, Laser and Cosmetic Surgery. Dr. Ibrahimi has trained at the most prestigious medical institutions in the country. He is one of the foremost physicians in the diagnosis and treatment of all types of skin cancer, as well as medical and cosmetic issues involving the skin. He has been honored as a Castle-Connolly Top Doctor since 2016 for his outstanding patient care.
Dr. Ibrahimi was born and raised in New York City. He graduated from Stuyvesant High School and then attended New York University for both his undergraduate and medical school education. He is a graduate of the rigorous MD-PhD program and was honored with the Sulzberger award given to the top graduating medical student in dermatology. He then completed his Dermatology training at Harvard Medical School working at Massachusetts General Hospital, Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, Children’s Hospital of Boston, Dana Farber Cancer Institute and the Boston Veteran’s Hospital. Omar then completed a fellowship program in Mohs and Reconstructive Surgery, Laser and Cosmetic Surgery at the University of California – Davis.
Dr. Omar Ibrahimi is accredited by the American College of Mohs Surgery, the American Society for Dermatologic Surgery, the American Society for Lasers in Surgery and Medicine and the American Academy of Dermatology. He is well-known nationally and internationally, having been an invited speaker at numerous national meetings, and has written extensively about Mohs Surgery, Laser and Cosmetic Procedures. Dr. Ibrahimi has published many articles on skin cancer surgery, laser and cosmetic procedures in leading medical journals. He has also performed tens of thousands of cases of Mohs Surgery and Laser and Cosmetic procedures. Dr. Ibrahimi has been responsible for unveiling and optimizing many of the latest cosmetic procedures that have hit the market in recent years and his practice is among the first to receive the latest innovations in aesthetic dermatology.
Dr. Ibrahimi has served as a Visiting Assistant Professor of Dermatology at Harvard Medical School in the Wellman Center for Photomedicine. The Wellman Center for Photomedicine is the world’s leading research center, where the majority of today’s laser and cosmetic technologies were invented and tested. He is an active participant in many clinical trials of new technologies. Prior to founding the Connecticut Skin Insititute, Dr. Ibrahimi was also an Assistant Professor of Dermatology, Dermatologic Surgery and Mohs Surgery at the University of Connecticut, and served as the Director of Laser and Cosmetic Surgery.
Dr. Ibrahimi prides himself on treating his patients, not just their skin cancer or cosmetic concern. His goal is to provide you with the best possible medical care in a friendly office environment.
Boncheol Goo, MD, MSc
Chief Director
Naeum Dermatology and Aesthetics Clinic, Seoul, Korea
Boncheol (Leo) GOO is a board-certified dermatologist/dermatologic surgeon based in Seoul, Korea. He is serving as a chief director of Naeum Dermatology and Aesthetics Clinic. He finished his dermtologic residency at Severance hospital, after graduating from Yonsei University College of Medicine. He served as a faculty in Seoul National University hospital in Seoul and Lutronic corporation (Now Cynosure-Lutronic) for years, continuing many roles and resposibilities in dermatologic and scientific societies, and industrial partners mostly on R&D, communication and clinical application. His academic interests focus on scar, medical devices, dermatosurgery and entrepreneurship in the medical and engineering fields.
Key:
Complete
Next
Failed
Available
Locked